These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25209194)

  • 1. Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness.
    Kaur H; Jajodia A; Grover S; Baghel R; Jain S; Kukreti R
    Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):635-46. PubMed ID: 25209194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.
    Kaur H; Jajodia A; Grover S; Baghel R; Gupta M; Jain S; Kukreti R
    PLoS One; 2014; 9(7):e102556. PubMed ID: 25025909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor 3 is associated with heroin dependence but not depression or schizophrenia in a Chinese population.
    Jia W; Zhang R; Wu B; Dai ZX; Zhu YS; Li PP; Zhu F
    PLoS One; 2014; 9(1):e87247. PubMed ID: 24498053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.
    Bishop JR; Reilly JL; Harris MS; Patel SR; Kittles R; Badner JA; Prasad KM; Nimgaonkar VL; Keshavan MS; Sweeney JA
    Psychopharmacology (Berl); 2015 Jan; 232(1):145-54. PubMed ID: 25096017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population.
    Tochigi M; Suga M; Ohashi J; Otowa T; Yamasue H; Kasai K; Kato T; Okazaki Y; Kato N; Sasaki T
    Schizophr Res; 2006 Dec; 88(1-3):260-4. PubMed ID: 16904291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of single-nucleotide polymorphisms in a metabotropic glutamate receptor GRM3 gene subunit to alcohol-dependent male subjects.
    Xia Y; Wu Z; Ma D; Tang C; Liu L; Xin F; Zhu D; Hu J
    Alcohol Alcohol; 2014; 49(3):256-60. PubMed ID: 24585043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population.
    Chen Q; He G; Chen Q; Wu S; Xu Y; Feng G; Li Y; Wang L; He L
    Schizophr Res; 2005 Feb; 73(1):21-6. PubMed ID: 15567072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for association between polymorphisms in GRM3 and schizophrenia.
    Norton N; Williams HJ; Dwyer S; Ivanov D; Preece AC; Gerrish A; Williams NM; Yerassimou P; Zammit S; O'Donovan MC; Owen MJ
    BMC Psychiatry; 2005 May; 5():23. PubMed ID: 15892884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk.
    Saini SM; Mancuso SG; Mostaid MS; Liu C; Pantelis C; Everall IP; Bousman CA
    Transl Psychiatry; 2017 Aug; 7(8):e1196. PubMed ID: 28786982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of relationship between GRM3 polymorphisms and cognitive function in schizophrenia of Han Chinese.
    Chang M; Sun L; Liu X; Sun W; Ji M; Wang Z; Wang Y; You X
    Psychiatry Res; 2015 Oct; 229(3):1043-6. PubMed ID: 26187343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication study and meta-analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case-control population.
    Albalushi T; Horiuchi Y; Ishiguro H; Koga M; Inada T; Iwata N; Ozaki N; Ujike H; Watanabe Y; Someya T; Arinami T
    Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):392-6. PubMed ID: 17948896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia.
    Nicodemus KK; Kolachana BS; Vakkalanka R; Straub RE; Giegling I; Egan MF; Rujescu D; Weinberger DR
    Hum Genet; 2007 Feb; 120(6):889-906. PubMed ID: 17006672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.
    Tsunoka T; Kishi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Inada T; Ozaki N; Iwata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):875-9. PubMed ID: 19386277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of GRM3 polymorphism with white matter integrity in schizophrenia.
    Mounce J; Luo L; Caprihan A; Liu J; Perrone-Bizzozero NI; Calhoun VD
    Schizophr Res; 2014 May; 155(1-3):8-14. PubMed ID: 24680030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia.
    Fujii Y; Shibata H; Kikuta R; Makino C; Tani A; Hirata N; Shibata A; Ninomiya H; Tashiro N; Fukumaki Y
    Psychiatr Genet; 2003 Jun; 13(2):71-6. PubMed ID: 12782962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes.
    Stevenson JM; Reilly JL; Harris MS; Patel SR; Weiden PJ; Prasad KM; Badner JA; Nimgaonkar VL; Keshavan MS; Sweeney JA; Bishop JR
    Transl Psychiatry; 2016 Feb; 6(2):e739. PubMed ID: 26905411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of the Level of Serum Prolactin with Polymorphic Variants of the GRIN2A, GPM3, and GPM7 Genes in Patients with Schizophrenia Taking Conventional and Atypical Antipsychotics].
    Tiguntsev VV; Gerasimova VI; Kornetova EG; Fedorenko OY; Kornetov AN; Goncharova AA; Poltavskaya EG; Boyko AS
    Mol Biol (Mosk); 2023; 57(1):47-55. PubMed ID: 36976738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia.
    Bishop JR; Miller del D; Ellingrod VL; Holman T
    Hum Psychopharmacol; 2011 Jan; 26(1):28-34. PubMed ID: 21344500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study.
    Jönsson EG; Saetre P; Vares M; Andreou D; Larsson K; Timm S; Rasmussen HB; Djurovic S; Melle I; Andreassen OA; Agartz I; Werge T; Hall H; Terenius L
    Neuropsychobiology; 2009; 59(3):142-50. PubMed ID: 19439994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.
    Egan MF; Straub RE; Goldberg TE; Yakub I; Callicott JH; Hariri AR; Mattay VS; Bertolino A; Hyde TM; Shannon-Weickert C; Akil M; Crook J; Vakkalanka RK; Balkissoon R; Gibbs RA; Kleinman JE; Weinberger DR
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12604-9. PubMed ID: 15310849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.